Unique ID issued by UMIN | UMIN000034591 |
---|---|
Receipt number | R000039427 |
Scientific Title | Carboplatin + nab-Paclitaxel treatment for non-small lung cancer with malignant pleural effusion -phase II trial- |
Date of disclosure of the study information | 2018/10/24 |
Last modified on | 2020/04/23 14:17:39 |
Carboplatin + nab-Paclitaxel treatment for non-small lung cancer with malignant pleural effusion -phase II trial-
Carboplatin + nab-Paclitaxel treatment for malignant pleural effusion
Carboplatin + nab-Paclitaxel treatment for non-small lung cancer with malignant pleural effusion -phase II trial-
Carboplatin + nab-Paclitaxel treatment for malignant pleural effusion
Japan |
Non-small lung cancer
Pneumology |
Malignancy
NO
Efficacy and safety of Carboplatin + nab-Paclitaxel treatment for non-small lung cancer with malingnant pleural effusion
Safety,Efficacy
Confirmatory
Pragmatic
Phase II
Control rate for malignant pleural effusion
RR, PFS, OS
Safety, one-year survival rate
Time for increase of pleural effusion
Rate of patients who did not require pleurodesis
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
NO
NO
Institution is not considered as adjustment factor.
NO
No need to know
1
Treatment
Medicine |
CBDCA + nab-Paclitaxel
20 | years-old | <= |
Not applicable |
Male and Female
1) Histologically proven non-small lung cancer
2) Histologically proven malignant effusion
3) Age over 20-years old
4) Performance status (ECOG) = 0-2
5) Never used of anti-cancer treatment except for either kinase treatment or immuno-check point inhibitor
6) Eligible for adjuvant or relapse after surgical treatment
7) Surgical treatment after 6 weeks
8) Adjuvant treatment after one-year
9) Adequate organ functions
10) Patients who have estimated life expectancy longer than 12 weeks
11) Written informed consent
1) Allergy for either nab-Paclitaxel or Paclitaxel
2) Severe complications such as intersitial pneumonia, CHF, CRF, liver damage, uncontrolled DM or HT
3) Symptomatic brain metastasis
4) Need for dainage
5) History of pleurodesis
6) Surgical treatment within 2 weeks
7) Active infection
8) Active multiple malignancy
9) Uncontrolled mental sympotoms
10) Pregnancy or pregnant possibiltiy
11) Administration of corticosteroids
12) Patients whom doctor consider ineligible
25
1st name | Masaki |
Middle name | |
Last name | Fujita |
Fukuoka University, Facutly of Medicine
Department of Respiratory Medicine
814-0180
7-45-1 Nanakuma, Jonanku, Fukuoka
0928011011
mfujita@fukuoka-u.ac.jp
1st name | Fumiyasu |
Middle name | |
Last name | Igata |
Fukuoka University, Facutly of Medicine
Department of Respiratory Medicine
814-0180
7-45-1 Nanakuma, Jonanku, Fukuoka
0928011011
figata@fukuoka-u.ac.jp
Fukuoka University, Facutly of Medicine,
Department of Respiratory Medicine
Fukuoka University, Facutly of Medicine,
Department of Respiratory Medicine
Self funding
JAPAN
Fukuoka University - Medical Ethics Review Board
7-45-1 Nanakuma, Jonanku, Fukuoka
0928011011
cawati@fukuoka-u.ac.jp
NO
福岡大学西新病院(福岡県)、福岡大学筑紫病院(福岡県)、福岡徳洲会病院(福岡県)、福西会病院(福岡県)
2018 | Year | 10 | Month | 24 | Day |
Unpublished
0
Registration is not expected.
2020 | Year | 04 | Month | 23 | Day |
Terminated
2018 | Year | 04 | Month | 01 | Day |
2018 | Year | 10 | Month | 16 | Day |
2018 | Year | 11 | Month | 01 | Day |
2022 | Year | 03 | Month | 31 | Day |
2018 | Year | 10 | Month | 22 | Day |
2020 | Year | 04 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039427
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |